Auteurs Wiedemann GM, Aithal C, Kraechan A, Heise C, Cadilha BL, Zhang J, Duewell P, Ballotti R, Endres S, Bertolotto C, Kobold S
Translational oncology Feb 2019
Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.Auteurs Leclerc J, Garandeau D, Pandiani C, Gaudel C, Bille K, Nottet N, Garcia V, Colosetti P, Pagnotta S, Bahadoran P, Tondeur G, Mograbi B, Dalle S, Caramel J, Levade T, Ballotti R, Andrieu-Abadie N, Bertolotto C
Oncogene Fév 2019
E2F1 inhibition mediates cell death of metastatic melanoma.Auteurs Rouaud F, Hamouda-Tekaya N, Cerezo M, Abbe P, Zangari J, Hofman V, Ohanna M, Mograbi B, El-Hachem N, Benfodda Z, Lebeau A, Tulic MK, Hofman P, Bertolotto C, Passeron T, Annicotte JS, Ballotti R, Rocchi S
Cell death & disease Mai 2018
Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.Auteurs El-Hachem N, Habel N, Naiken T, Bzioueche H, Cheli Y, Beranger GE, Jaune E, Rouaud F, Nottet N, Reinier F, Gaudel C, Colosetti P, Bertolotto C, Ballotti R
Cell death and differentiation Mar 2018
Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.Auteurs Ohanna M, Cerezo M, Nottet N, Bille K, Didier R, Beranger G, Mograbi B, Rocchi S, Yvan-Charvet L, Ballotti R, Bertolotto C
Genes & development Mar 2018
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.Auteurs Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M, Bille K, Hofman V, Bossis G, Marco de Donatis G, Strub T, Cheli Y, Ohanna M, Luciano F, Marchetti S, Rocchi S, Birling MC, Avril MF, Poulalhon N, Luc T, Hofman P, Lacour JP, Davidson I, Bressac-de Paillerets B, Ballotti R, Marine JC, Bertolotto C
Journal of the National Cancer Institute Apr 2017